Search Results 911-920 of 19762 for Hepatitis+C

1. A Trial Comparing Unrelated Donor BMT With IST for Pediatric and Young Adult Patients With Severe Aplastic Anemia (TransIT, BMT CTN 2202) - Mayo Clinic

   Active Hepatitis B or C. This only needs to be excluded in patients where there is clinical suspicion of hepatitis (e.g., elevated LFTs). 8. Female patients ...

2. An Efficacy, Safety And Tolerability Study Of Ixmyelocel-T Administered Via Transendocardial Catheter-based Injections To Subjects With Heart Failure Due To Ischemic Dilated Cardiomyopathy (IDCM) - Mayo Clinic

   Active hepatitis B surface antigen (HBsAg) or hepatitis C virus (HCV) antibodies ... hepatitis B core antibody; human T lymphotropic virus I/II. Subjects ...

3. Tom Vanderwell's Mayo Clinic Story

   Carol's Story: Hepatitis C and Liver Cancer · Clinical Nurse Specialist – A Day in the Life at Mayo Clinic. Related Articles. How advanced surgical skills ...

4. Study of MLN4924 Plus Azacitidine in Treatment-Naïve Patients With Acute Myelogenous Leukemia (AML) Who Are 60 Years or Older - Mayo Clinic

   Known hepatitis B surface antigen-positive, or known or suspected active hepatitis C infection; Known hepatic cirrhosis or severe pre-existing hepatic ...

5. A Multi-Center Study Evaluating KTE-X19 in Pediatric and Adolescent Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia - Mayo Clinic

   Known infection with HIV, hepatitis B (HBsAg positive) or hepatitis C virus (anti-HCV positive); Presence of fungal, bacterial, viral, or other infection ...

6. Durvalumab+/- Tremelimumab in Combination With Platinum Based Chemotherapy in Untreated Extensive-Stage Small Cell Lung Cancer (Caspian) - Mayo Clinic

   Active infection including tuberculosis, HIV, hepatitis B anc C; Active or prior documented autoimmune or inflammatory disorders; Uncontrolled intercurrent ...

7. A Study of the Relationship Between Fetal (Pre-birth Infant) DNA and the Maternal Immune Response - Mayo Clinic

   Chronic, active viral infections, including HIV-1/2, HTLV-1/2, hepatitis B/C. Known autoimmune disease (e.g., rheumatoid arthritis or systemic lupus ...

8. A Phase 2 Study to See if Simtuzumab (GS-6624) is Safe and Works in Idiopathic Pulmonary Fibrosis (IPF) - Mayo Clinic

   Subjects cured of Hepatitis C are eligible. Exclusion Criteria: Significant diseases other than IPF; Obstructive lung disease; Aortic aneurysm greater than or ...

9. Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's) - Mayo Clinic

   Known infection with human immunodeficiency virus (HIV), hepatitis C, or a positive hepatitis B surface antigen; Inability to comply with study guidelines ...

10. Nausea and vomiting - Mayo Clinic

    Hepatitis C: How common is sexual transmission? Hepatitis C: What happens in end-stage liver disease? ... How do COVID-19 antibody tests differ from diagnostic ...